TrialInternational journal of hematology2018

Safety and efficacy of high-dose ranimustine (MCNU) containing regimen followed by autologous stem cell transplantation for diffuse large B-cell lymphoma.

Yoshihiro Kameoka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.